Le clinique
Guide pratique

Cycle: Compulsions are used to neutralize anxiety but create a self-reinforcing loop of distress.

Lifespan: A neurodevelopmental condition often persisting into adulthood, impacting executive function.

Evidence-Based: Core skill in DBT, ACT, and relapse prevention.

Clinical Focus: Intense fear of abandonment and chronic feelings of emptiness. DBT is the first-line, evidence-based treatment.

Clinical Standard: Published by the American Psychiatric Association (2022). The primary diagnostic authority used in our platform.

Clinical Utility: Core for BPD and chronic suicidality. Modules: Mindfulness, Distress Tolerance, Emotion Regulation, Interpersonal Effectiveness.

Distinction: Hypomania is less severe than full mania and does not cause marked functional impairment.

Vendor Management: Ensures that third-party tools (like HiBoop) meet HIPAA security standards.

Benefit: Leverages social learning and reduced isolation (Yalom's factors).

Efficacy: Proven to improve patient outcomes by up to 40% and reduce time to remission.

Scoring: 10+ suggests moderate depression. Used globally for longitudinal tracking.

Clinical Logic: Essential for choosing the right protocol (e.g., Bipolar vs. ADHD).

Impact: The rule in mental health (e.g., Anxiety + Depression). Increases treatment complexity.

Clinical Utility: Highly sensitive to change. Essential for monitoring treatment progress.

Financial: In-network care has much lower cost-sharing for patients.

Physicality: Often presents with muscle tension, fatigue, and sleep disturbance for at least 6 months.

Global Standard: Endorsed by the World Health Assembly in 2019 and effective since 2022. Used for international clinical reporting and billing.

Compliance: Requires specific technical, physical, and administrative safeguards for PHI.

Clinical Utility: High sensitivity for adult symptoms. Often the first step in ADHD assessment.

Standard: The baseline for most mental health treatment delivery.

Clinical Standard: First-line treatment for anxiety and depression. Focuses on identifying cognitive distortions and using behavioral activation.

Access: OON providers often issue Superbills so patients can seek partial reimbursement.

Administrative: Can take 90-120 days. CAQH is the primary database used for this in the US.

Outcome: The strongest predictor of successful treatment across all therapy modalities.

Indication: Essential for long-term recovery in addiction and TRD.

Criteria: At least 2 weeks of 5+ symptoms. The leading cause of disability worldwide.

Principles: Safety, Trustworthiness, Peer Support, Collaboration, and Empowerment.

Bridge: High-intensity day treatment avoiding full inpatient stay.

Indication: Used for screening and providing a provisional PTSD diagnosis.

Severity: Mania causes marked impairment. Psychosis is common during episodes.

Security: Highly protected under HIPAA. Breach results in significant legal and financial penalties.

Clinical Evidence: Insurers use this to decide whether to pay for a specific level of care.

Symptoms: Flashbacks, avoidance, negative cognitions, and hyperarousal persisting >1 month.

Level of Care: Patients live at home but attend daily groups.

Clinical Utility: Essential for substance use disorders and medication adherence using OARS skills.

Workflow: A common administrative hurdle that can delay access to specialized treatments or meds.

Criterion Standard: Best tool for detecting risky drinking patterns before dependence.

Global Standard: Version 2.0 provides clinical protocols for scaling up care for mental, neurological, and substance use disorders.

US Law: Requires insurers to cover mental health at the same level as medical/surgical care.

Symptoms: Hallucinations, delusions, and disorganized thinking. Early intervention is critical.

Spectrum: Broad range of support needs. ICD-11 consolidated Asperger's and PDD-NOS into this single category.

Diagnosis: Use despite harmful consequences and physiological changes in brain circuitry.

Admin: A common barrier to specialized care like TMS or Spravato.

Context: Essential for holistic care. Captured in EHRs via V-codes or Z-codes.

Assessment: Often measured by WHODAS. A key criteria for many DSM-5 diagnoses.

Clinical Priority: Standardizes the assessment of suicidal ideation and behavior intensity.

Goal: Full remission means returning to the premorbid level of functioning.

VA/DoD Guideline: Strongly recommended for PTSD. Addresses the five stuck point themes: Safety, Trust, Power/Control, Esteem, and Intimacy. Outcomes tracked session-by-session with PCL-5.

ICD-11 Innovation: Adds Disturbances in Self-Organization (DSO) to standard PTSD symptoms.

Indication: Highly effective for depression triggered by life events such as grief or role transitions.

A widely used psychological instrument for measuring the perception of stress (Cohen 1983).

Observation: A sign of mania, BPD, or neurological impairment.

Major cause of treatment non-adherence in schizophrenia and bipolar.

Side Effect: A common and highly distressing reaction to antipsychotics.

Clinical Note: Highly effective for severe, treatment-resistant depression and catatonia. Modern ECT is safe and controlled.

Clinical Utility: Used in primary care to detect risky substance use. Developed by an international team of researchers under the World Health Organization.

An authoritative 18-item scale for current and retrospective ADHD assessment (Barkley 2011).

Framework: Views the mind as a system of Exiles, Managers, and Firefighters led by the core 'Self'.

Dynamic Skill: Can be learned and strengthened through therapy.

Differentiation: Teaches clients to 'defuse' from thoughts and pursue value-driven actions despite symptoms.

A 5-item screener for predicting aberrant drug-related behaviors in chronic pain patients.

Technique: Uses 'The Miracle Question' to identify existing strengths and exceptions to the problem.

Certifies PMHNP-BCs (Psychiatric-Mental Health Nurse Practitioners).

A 5-item measure assessing the severity and frequency of suicidal ideation.

Philosophy: Shifts focus from 'cure' to living a satisfying life.

Workflow: Clinicians often have 'peer-to-peer' calls during this process.

A highly sensitive 5-item screening tool for anorexia and bulimia nervosa.

Clinician-Rated: Used to measure symptom type and severity during treatment.

Billing: Owns the CPT code set used for all medical and psych billing.

A 50-item self-report scale measuring autistic traits in adults.

Community: Provides local services and housing across Canada.

Support: Focuses on peer-led education and family-to-family support.

Standards: Sets the ethical code and LCSW credentialing standards.

Indication: FDA-approved for Treatment-Resistant Depression (TRD) and OCD when medications are ineffective.

Accredits psychology programs and advocates for national policy.

Clinical Science: HiBoop only utilizes instruments with high face and construct validity established in peer-reviewed literature.

Focus: Emphasizes a developmental and wellness model of mental health.

Focus: Targets interactions between members rather than individuals.

Future: MBC tools like HiBoop are the foundation of VBC implementation.

Screening: High sensitivity is critical for screening tools (like the C-SSRS) to ensure no at-risk patients are missed.

A dimensional rating scale for ADHD symptoms in children and adolescents.

Advocacy: Pushes for full practice authority for NPs and PMHNPs.

Assesses potential for misuse of opioid medications in chronic pain populations.

Clinical Tool: Proven to reduce shame and increase therapeutic outcomes.

Mechanism: Uses bilateral stimulation to help the brain reprocess traumatic information without extensive verbal recounting.

A comprehensive 218-item tool (v6.0) for assessing pathological dissociation and DID.

Measures functional impairment across multiple life domains in adults with ADHD.

Role: Approves psychotropics and Digital Therapeutics (DTx).

A retrospective screening tool for childhood ADHD symptoms in adults.

Mechanism: Gradual exposure to triggers while refraining from compulsions to break the reinforcement cycle.

The Lawton-Brody scale measuring functional capacity in older adults.

Criteria: Psychotic symptoms must occur for at least 2 weeks in the absence of a mood episode.

Clinical Marker: A core symptom of MDD and a negative symptom of Schizophrenia.

Diagnosis: High specificity helps avoid 'false positives' and unnecessary treatment or stigma.

Mechanism: Works via 'habituation' and 'inhibitory learning'. First-line evidence-based approach for Phobias and PTSD.

A 25-item tool measuring executive function strengths and weaknesses.

Observations: Described as Full, Flat, Blunted, Labile, or Incongruent.

Prevention: Focuses on early intervention ('Before Stage 4').

An 8-item brief version of the DES included as an emerging measure in DSM-5.

Signs: Confusion, fever, rigidity. Caused by drug interactions.

Emerging Field: Rapid-acting treatment for depression and PTSD, leveraging the 'neuroplastic window' created by ketamine.

A 16-item version of Jorm's IQCODE adapted for self-report by the patient.

Clinical Distinction: Helps prevent the misdiagnosis of Bipolar as Unipolar Depression.

Self-Care: Represents a shift in the provider's worldview due to exposure.

Telehealth: Essential for ensuring correct reimbursement for virtual sessions during and after the PHE.

Therapeutic Tool: Provides a window into the client's attachment patterns.

Risk: Often irreversible. Involves repetitive movements of face and tongue.

A new outcome measure (Adamis 2024) specifically for adult ADHD clinical tracking.

E.g., Treating 'Emotional Dysregulation' across BPD, ADHD, and PTSD.

Clinical Marker: A hallmark of mania or severe anxiety.

Trauma Response: A spectrum from mild (daydreaming) to severe (DID).

Public Health: Focuses on safety (e.g., needle exchange) over abstinence.

Origin: Developed by Jon Kabat-Zinn. Secular and standardized, widely used in clinical settings.

Technical: Provides a standardized way for different EHRs to understand that a set of scores belongs to a specific validated instrument.

A primary symptom of mania. Connections are discernable but frantic.

Clinical Science: High reliability (e.g., test-retest) ensures that changes in scores reflect actual clinical change rather than measurement error.

Research: Combines clinical care and policy development in Toronto.

Safety: Crucial for early detection of postpartum depression in the first year.

Policy: Varies by state. Critical for the financial viability of virtual practices.

Populations: Developmentally appropriate for children ages 3-12.

Licensure: Issues the NCC credential and manages the NCMHCE exam.

Focus: Uses the therapeutic relationship to explore how past experiences shape current behavior and feelings.

Clinical Priority: Requires advanced interventions like Ketamine, TMS, or ECT.

Baseline Goal: The desired state for mood disorder maintenance therapy.

Certification: Issues the CCC (Canadian Certified Counsellor) designation.

Multi-Source: Uses parent and teacher forms to assess symptoms and performance in children 6-12.

Practice: Must be monitored to ensure it doesn't impact clinical objectivity.

Provider Health: Leads to a reduced capacity for empathy and nurturing.

Indication: Significant functional impairment in the final week before menses. More severe than PMS.

Clinically known as Schizophasia. A sign of severe disorganized thinking.

Distinguished from tangentiality by the eventual return to the original topic.

Usage: Traits that impact care but do not cause pervasive impairment.

Compliance: Critical for multi-specialty clinics and ownership models.

A 3-item screener for gambling disorder derived from the DSM-IV criteria.

Prevention: Early detection in this phase can prevent full psychosis.

Associated with Autism, Tourette's, and Schizophrenia.

A negative symptom of schizophrenia reflecting a disruption in thought process.

A disorder of thought process where answers are only partially relevant.

A negative symptom often seen in schizophrenia and severe depression.

Technique: Empowers clients to rewrite their life stories.

Occurs in both Mood Disorders and Schizophrenia. A clinical emergency.

Indication: Used for ADHD and Anxiety to improve self-regulation.

Treatment: MBT is evidence-based for BPD and trauma.

Technique: Uses the 'Empty Chair' to resolve unfinished business.